The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.
By M. Cooperberg, D. Lubeck, M. Meng, S. Mehta, P. Carroll. Journal of Clinical Oncology, 2004
594 citations recorded by the source corpus.
Subfields: Epidemiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/e2d64ed401aa272d38a9158125e74c53544e1146
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- B. Leibovich
- M. Blute
- John C. Cheville
- Christine M. Lohse
- R. H. Thompson
- S. Boorjian
- E. Kwon
- Hatem Amer
Citations in the corpus
- Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. (2008, background): “Therefore, we see no reason why low volume Gleason score 7 should not be included in trials evaluating focal therapy, since it is this same group of patients who are likely to benefit from some form of therapy, and avoid the toxicity of whole gland treatment.(11) Furthermore, it could be argued that”
- Nonholonomic Modeling of Needle Steering (2006, unknown): “brachytherapy [2], involving implantation of thin needles to deposit radioactive seeds [ 3 ].”
- Overdiagnosis and Overtreatment of Prostate Cancer (2014, unknown): “3% (1999–2001) [33].”